department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Spiriva Handihaler · pharmadog

pharmadog
drugs
Spiriva Handihaler

drug

patient view →

Spiriva

Marketedupdated 2mo ago

by Boehringer Ingelheim Corp

Approved

community read0 votes

indications

investigational

COPD

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Spiriva Handihaler

generic

tiotropium bromide

indication

Bronchospasm

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 19, 2026

12 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Apr 16, 2031patentUS 8733341*PED4.8y
Sep 13, 2028patentUS 7837235*PED2.2y
Sep 30, 2027patentUS 9027967*PED1.2y
Apr 10, 2027patentUS 7396341*PED277d
Jul 19, 2026patentUS 8022082*PED12d
Jan 19, 2026formulationUS 8022082

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying Spiriva

phase1A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjectsrecruitingn=57
phase4ANTES B+ Clinical Trialterminatedn=48
—Characteristics of Pts Initiating Spiriva Respimat in Asthmacompletedn=116,133
—Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drugterminatedn=9
phase4Anti-inflammatory Effects of Tiotropium in Patients with Stable COPDcompletedn=37
phase1A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditionsactive not recruitingn=186
—Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greececompletedn=1,396
phase1A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)unknownn=39

more trials →